Literature DB >> 21566560

Summary of notifiable diseases: United States, 2009.

.   

Abstract

The Summary of Notifiable Diseases--- United States, 2009 contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable infectious diseases in the United States for 2009. Unless otherwise noted, the data are final totals for 2009 reported as of June 30, 2010. These statistics are collected and compiled from reports sent by state health departments and territories to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). The Summary is available at http://www.cdc.gov/mmwr/summary.html. This site also includes Summary publications from previous years.

Entities:  

Mesh:

Year:  2011        PMID: 21566560

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  39 in total

1.  The global dimensions of public health preparedness and implications for US action.

Authors:  Melinda Moore
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  "I've heard some things that scare me". Responding with empathy to parents' fears of vaccinations.

Authors:  Kenneth Holler; Anthony Scalzo
Journal:  Mo Med       Date:  2012 Jan-Feb

3.  A Chlamydia-specific C-terminal region of the stress response regulator HrcA modulates its repressor activity.

Authors:  Allan L Chen; Adam C Wilson; Ming Tan
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

4.  Comparing active and passive varicella surveillance in Philadelphia, 2005-2010: recommendations for the transition to nationwide passive varicella disease surveillance.

Authors:  Kendra Viner; Dana Perella; Adriana Lopez; Stephanie Bialek; Michael Nguyen; Niya Spells; Barbara Watson
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

5.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

Review 6.  Rapid diagnostic HCV antibody assays.

Authors:  Bryce D Smith; Amy Jewett; Jan Drobeniuc; Saleem Kamili
Journal:  Antivir Ther       Date:  2012-12-07

7.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

8.  Completeness of reporting of race and ethnicity data in the nationally notifiable diseases surveillance system, United States, 2006-2010.

Authors:  Nelson Adekoya; Benedict I Truman; Umed A Ajani
Journal:  J Public Health Manag Pract       Date:  2015 Mar-Apr

9.  Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.

Authors:  Maarten J Voordouw; Haley Tupper; Özlem Önder; Godefroy Devevey; Christopher J Graves; Brian D Kemps; Dustin Brisson
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-21       Impact factor: 2.133

10.  Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.

Authors:  Roderick A MacPhee; Wayne L Miller; Gregory B Gloor; John K McCormick; Jo-Anne Hammond; Jeremy P Burton; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.